Tony Kim | Chief Financial Officer |
Peter Hoang | President and Chief Executive Officer |
Mythili Koneru | Chief Medical Officer |
Matt Biegler | Oppenheimer |
Jackson Harvey | Nomura |
Tony Butler | ROTH Capital |
Yun Zhong | Janney |
Jordyn Fantuzzi | Piper Sandler |
Good afternoon, ladies and gentlemen and welcome to the Marker Therapeutics First Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time.
As a reminder, this conference call is being recorded.
It’s now my pleasure to introduce your host, Mr.